Lb Pharmaceuticals (LBRX) Current Leases (2024 - 2026)

Lb Pharmaceuticals (LBRX) recorded quarterly Current Leases of $730000.0 in Q1 2026, little changed quarter-over-quarter from $730000.0 in Q4 2025.

Lb Pharmaceuticals (LBRX) Current Leases (2024 - 2026) Analysis & Trends

Lb Pharmaceuticals' Current Leases history runs 3 years deep, the most recent figure standing at $730000.0 for Q1 2026.

  • In Q1 2026, Current Leases changed N/A year-over-year to $730000.0; the TTM figure through Mar 2026 stood at $730000.0 (changed N/A YoY), while the FY2025 annual figure was $730000.0, up 49.9% from the prior year.
  • Current Leases was $730000.0 for Q1 2026 at Lb Pharmaceuticals, roughly flat from $730000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $730000.0 in Q3 2025 to a low of $487000.0 in Q4 2024.
  • Historically, Current Leases has averaged $669250.0 across 3 years, with a median of $730000.0 in 2025.
  • Biggest YoY gain for Current Leases was 49.9% in 2025; the steepest drop was 49.9% in 2025.
  • A 3-year view of Current Leases shows it stood at $487000.0 in 2024, then surged by 49.9% to $730000.0 in 2025, then changed by 0.0% to $730000.0 in 2026.
  • The last three Current Leases figures came in at $730000.0 (Q1 2026), $730000.0 (Q4 2025), and $730000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 83,991.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 7.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Lb Pharmaceuticals 843.30 Mn 843.30 Mn - 730,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 730,000.00
Dec 31, 2025 730,000.00
Sep 30, 2025 730,000.00
Dec 31, 2024 487,000.00